- Ann H. Partridge, MD, MPH "I want patients to understand their options and have choices." - Lawrence J. Solin, MD We need to tailor therapies better for individual patients….the problem is that we overtreat the many to benefit the few." - Shelley Hwang, MD, MPH "There is risk both with treatment and with treatment deescalation, and we need to be able to quantify that trade off in a much better way for an individual patient." - Lars J. Grimm, MD, MHS
"The next few years will witness the publication of major trial results and potentially chart a new course of DCIS management."
Demystifying Ductal Carcinoma in Situ

Helping patients understand ductal carcinoma in situ (DCIS) and make informed treatment decisions.

Helping patients understand ductal carcinoma in situ (DCIS) and make informed treatment decisions.

Get the latest DCIS updates

Your donation goes directly to expanding the information on this website